Rosuvastatin in the Prevention of Stroke among Men and Women with Elevated Levels of C-Reactive Protein: The JUPITER Trial

Summary

Evidence from the Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin [JUPITER; NCT00239681] trial [Ridker PM et al. N Engl J Med 2008] provides support for the use of statins to prevent strokes in healthy individuals with low LDL cholesterol but elevated high-sensitivity C-reactive protein levels.

  • Neurology Clinical Trials
  • Prevention & Screening
  • Lipid Disorders
  • Cerebrovascular Disease
View Full Text